LegoChem’s $1.2bn ADC Platform Deal With Amgen Signals Continued Big Pharma Interest

Fourth ADC Platform License Deal For LCB

 
• By Jung Won Shin
  
ADC
LegoChem Aims To Further Expand ADC Partnerships With Global Pharmas • Source: Shutterstock

More from Business

More from Scrip